Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Palatin Technologies Inc PTN

Healthcare Biotechnology
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with unmet medical need and commercial potential. Its new product development activities focus primarily on MC1r agonists... see more

Recent & Breaking News (NYSEAM:PTN)

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2015 Results

PR Newswire September 21, 2015

Palatin Technologies and Richter Terminate License Agreement for Bremelanotide for Female Sexual Dysfunction

PR Newswire September 21, 2015

Palatin Technologies, Inc. To Report Fourth Quarter Fiscal Year End 2015 Results

PR Newswire September 16, 2015

Palatin Technologies Supports FDA's Approval of the First-Ever Treatment for Female Sexual Dysfunction

PR Newswire August 18, 2015

Palatin Technologies Completes $30 Million Financing

PR Newswire July 6, 2015

Palatin Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder

PR Newswire June 4, 2015

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on May 13, 2015

PR Newswire May 13, 2015

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2015 Results

PR Newswire May 8, 2015

Palatin Technologies To Present At The 27th Annual ROTH Conference

PR Newswire March 6, 2015

Palatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction

PR Newswire February 20, 2015

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on February 13, 2015

PR Newswire February 13, 2015

Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2015 Results Teleconference and Webcast to be held on February 13, 2015

PR Newswire February 9, 2015

Palatin Technologies To Present At The BIO CEO & Investor Conference

PR Newswire February 6, 2015

Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

PR Newswire December 29, 2014

Palatin Completes $20 Million Equity and $10 Million Debt Financings

PR Newswire December 24, 2014

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014

PR Newswire November 18, 2014

Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2015 Results

PR Newswire November 13, 2014

Palatin Technologies To Present At The 13th Annual BIO Investor Forum

PR Newswire October 8, 2014

IPOs and Transactions Week in Review: September 29 - October 3

PR Newswire October 6, 2014

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Results

PR Newswire September 9, 2014